Medical cannabis products could require prescription in Ireland under certain conditions until the end of next month, the HSE has confirmed.
Legislation approving the five-year pilot was signed in 2019 by former Minister of Health Simon Harris.
The program enables medical advisors to prescribe cannabis-based treatments to a patient they care for if they have not responded to standard treatments. Suitable conditions include spasticity associated with multiple sclerosis; Nausea and vomiting associated with chemotherapy; and severe, treatment-resistant epilepsy.
The health care spokeswoman said yesterday, “HSE is working to set up the registry for the end of the second quarter.”
This week it also emerged that cannabis medicines that are only approved for the UK market will not do so